← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Moxifloxacino currently has availability issues reported in 4 European registers: Austria, Spain, Italy, Sweden.
Shortage ATC — · also listed as: MOXIFLOXACIN · MOXIFLOXACINO · MOXIFLOXACINA · moxifloxacinhydroklorid · data refreshed 9 September 2026
As of 9 September 2026, 4 of the 9 tracked registers list current availability issues for Moxifloxacino, covering 7 affected product presentations. The longest-running open report was filed in Austria on 2025-08-22 and has now been open for about 13 months. Where agencies state a cause, unexpectedly high demand lead with 1 of the 1 stated-cause reports. The furthest expected-resolution date currently on file is 2027-03-01; the earliest is 2026-09-30. Notably, 1 report has already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. Momentum is current, not historical: 3 of the open reports were filed within the last 90 days. The issue spread across registers over time rather than at once: Austria reported first (2025-08-22), with Italy following roughly 11 months later — a pattern typical of supply problems cascading between national markets. Registers in Spain, Italy, Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇦🇹 Austria | Limited availability Moxifloxacin ratiopharm 400 mg Filmtabletten | 2025-08-22 | — | — | register ↗ |
| 🇪🇸 Spain | Shortage MOXIFLOXACINO PENSA 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 5 comprimidos + 2 more productsMOXIFLOXACINO PENSA 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 7 comprimidos MOXIFLOXACINO QUALIGEN 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 5 comprimidos | 2025-12-08 | — | Existen otros medicamentos con el mismo principio activo y misma vía. Alternatives: Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración. | register ↗ |
| 🇮🇹 Italy | Shortage AVALOX | 2026-07-01 | 2026-09-30 | Elevata richiesta Alternatives: AIFA: import of a foreign equivalent can be authorised. | register ↗ |
| 🇸🇪 Sweden | Shortage Moxifloxacin Orion 400 mg Filmdragerad tablett + 1 more productsRivomoxi 400 mg Filmdragerad tablett | 2025-09-01 | 2027-03-01 | — Alternatives: Alternative(s) available — see the national register. | register ↗ |
Every individual register entry for Moxifloxacino in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇮🇹 IT | AVALOX | Shortage | 2026-07-01 | 2026-09-30 | Elevata richiesta |
| 🇪🇸 ES | MOXIFLOXACINO PENSA 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 5 | Shortage | 2026-06-21 | — | Existen otros medicamentos con el mismo principio activo y m |
| 🇪🇸 ES | MOXIFLOXACINO PENSA 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 7 | Shortage | 2026-06-21 | — | Existen otros medicamentos con el mismo principio activo y m |
| 🇸🇪 SE | Moxifloxacin Orion 400 mg Filmdragerad tablett | Shortage | 2026-05-04 | 2027-03-01 | |
| 🇪🇸 ES | MOXIFLOXACINO QUALIGEN 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | Shortage | 2025-12-08 | — | Existen otros medicamentos con el mismo principio activo y m |
| 🇸🇪 SE | Rivomoxi 400 mg Filmdragerad tablett | Shortage | 2025-09-01 | 2026-07-31 | |
| 🇦🇹 AT | Moxifloxacin ratiopharm 400 mg Filmtabletten | Limited availability | 2025-08-22 | — |
Yes. As of 9 September 2026, availability issues are reported in: Austria, Spain, Italy, Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-09-30 to 2027-03-01. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
6 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Moxifloxacino: BASG (Austria), AEMPS CIMA (Spain), AIFA (Italy), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Moxifloxacino — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/moxifloxacino/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Moxifloxacino availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/moxifloxacino/">Moxifloxacino shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>